Inventor · disambiguated record
Giuseppe Ronzitti
Also filed as: RONZITTI GIUSEPPE
6 granted patents·19 pending applications·10 citations·filing 2015–2025
76Inventor score
Top patents by PatentIndex Score
25 records- 0189US11421211B2Acid-alpha glucosidase variants and uses thereofGENETHON·Filed 2017·Granted Aug 23, 2022·4 cites·9 claims
- 0287US11339406B2Acid-alpha glucosidase variants and uses thereofGENETHON·Filed 2017·Granted May 24, 2022·3 cites·20 claims
- 0377US12305187B2Acid-alpha glucosidase variants and uses thereofGENETHON·Filed 2022·Granted May 20, 2025·0 cites·19 claims
- 0475US2025270590A1Acid-alpha glucosidase variants and uses thereofGENETHON·Filed 2025·Application pending·0 cites
- 0573US10471132B2Treatment of hyperbilirubinemiaGENETHON·Filed 2015·Granted Nov 12, 2019·3 cites·19 claims
- 0670US2024043867A1Acid-alpha glucosidase variants and uses thereofGENETHON·Filed 2022·Application pending·0 cites
- 0767US2023414724A1Treatment of hyperbilirubinemiaGENETHON·Filed 2023·Application pending·0 cites
- 0865US2022389399A1Acid-alpha glucosidase variants and uses thereofGENETHON·Filed 2022·Application pending·0 cites
- 0963US2023190965A1Treatment of glycogen storage disease iiiGENETHON·Filed 2022·Application pending·0 cites
- 1062US2022380807A1Method for reducing the expression of nkcc1 in a subjectINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1160US2021040503A1Acid-alpha glucosidase variants and uses thereofGENETHON·Filed 2020·Application pending·0 cites
- 1260US2022228167A1Peptide-Modified Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism and Increased Muscle TransductionGENETHON·Filed 2019·Application pending·0 cites
- 1360US2024350670A1Hybrid promoters for gene expression in muscles and in the cnsGENETHON·Filed 2022·Application pending·0 cites
- 1456US11541131B2Treatment of glycogen storage disease IIIGENETHON·Filed 2018·Granted Jan 3, 2023·0 cites·21 claims
- 1556US11427836B2Method for reducing the expression of NKCC1 in a subjectINST NAT SANTE RECH MED·Filed 2018·Granted Aug 30, 2022·0 cites·15 claims
- 1656US2023242905A1Method for Engineering Novel Hybrid AAV Capsids Through Hyper Variable Regions SwappingGENETHON·Filed 2021·Application pending·0 cites
- 1755US2023203534A1Vectors encoding a glucose-6-phosphatase (g6pase-a) for gene therapyGENETHON·Filed 2021·Application pending·0 cites
- 1852US2025041448A1Gene Therapy of Fibroblast Growth Factor 23 Related Hypophosphatemic DiseasesGENETHON·Filed 2020·Application pending·0 cites
- 1949US2019374619A1Treatment of hyperbilirubinemiaGENETHON·Filed 2019·Application pending·0 cites
- 2049US2023313152A1C-terminal truncated gde for the treatment of glycogen storage disease iiiGENETHON·Filed 2021·Application pending·0 cites
- 2147US2022162640A1Hybrid promoters for muscle expressionGENETHON·Filed 2020·Application pending·0 cites
- 2246US2019390224A1Acid-alpha glucosidase variants and uses thereofGENETHON·Filed 2017·Application pending·0 cites
- 2346US2022331408A1Treatment of glycogen storage disease (gsd)GENETHON·Filed 2020·Application pending·0 cites
- 2443US2021292724A1Mini-gde for the treatment of glycogen storage disease iiiGENETHON·Filed 2019·Application pending·0 cites
- 2540US2022280655A1New Adeno-Associated Virus (AAV) Variants and Uses Thereof for Gene TherapyINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Giuseppe Ronzitti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →